Key result
Pressure-guided balloon pulmonary angioplasty linked to ~54% higher hemodynamic success versus angiography-guided therapy.
Why the study?
Does pressure-guided balloon pulmonary angioplasty improve residual pulmonary hypertension and reduce complications compared to angiographic guidance in patients with CTEPH?
Cohort (n=95)
No
Does pressure-guided balloon pulmonary angioplasty improve residual pulmonary hypertension and reduce complications compared to angiographic guidance in patients with CTEPH?
Pressure-guided balloon pulmonary angioplasty with a target pressure ratio of 0.7 significantly improves hemodynamic outcomes and reduces procedural complications in patients with CTEPH.
May support pressure ratio-guided BPA in CTEPH; hypothesis-generating and requires randomized confirmation.
BACKGROUND: Balloon pulmonary angioplasty (BPA) has exhibited substantial progress in the management of chronic thromboembolic pulmonary hypertension (CTEPH). However, nearly one-half of the patients with CTEPH experience persistent pulmonary hypertension after undergoing BPA, emphasizing the need for enhanced therapies. OBJECTIVES: The authors sought to investigate the clinical significance of functional assessment-guided dilation of the pulmonary artery (PA) in patients with CTEPH undergoing BPA treatment. METHODS: The prospective single-center cohort study enrolled 95 patients who underwent 278 consecutive BPA sessions. Lung parenchymal perfusion was assessed via 2-dimensional perfusion angiography, and pressure catheter measurements were taken to determine the PA pressure ratios. The correlation between lung perfusion and the pressure ratio was analyzed to establish an optimal target pressure ratio. Patients were stratified into 2 groups, a pressure-guided group (n = 28) and an angiographic group (n = 63), to evaluate whether optimizing the pressure ratio led to improvements in residual PH and complications. RESULTS: The pressure ratio and lung perfusion measurements of 141 PA lesions were analyzed. A piecewise linear regression model identified a target pressure ratio of 0.7, associated with significant enhancement in lung perfusion. The pressure-guided strategy achieved a higher rate of mean pulmonary artery pressure <25 mm Hg (92.8% [26/28 patients] vs 60.3% [38/63 patients]; P = 0.001) and a concurrent reduction in BPA relevant complications (3.9% [4/101 sessions] vs 12.9% [23/177 sessions]; P = 0.019). CONCLUSIONS: Functional assessment-guided PA dilation with a target pressure ratio of 0.7 proved beneficial in BPA treatment for patients with CTEPH. This approach improved the residual PH and reduced complications, highlighting its potential to enhance CTEPH management outcomes.
No takes yet. Share an insight, caveat, or question.
Satoh et al. (2024) conducted a cohort in Chronic thromboembolic pulmonary hypertension (CTEPH) (n=95). Pressure-guided strategy vs. Angiographic strategy was evaluated on Mean pulmonary artery pressure <25 mm Hg (p=0.001). A pressure-guided strategy for balloon pulmonary angioplasty achieved a higher rate of mean pulmonary artery pressure <25 mm Hg than an angiographic strategy (92.8% vs 60.3%; P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: